Join Team Norway at NLSDays 2025
13 October 2025 - 14 October 2025
Conference
Are you a Norwegian health company ready to showcase your solutions on the international stage? Join the Norwegian pavilion at NLSDays 2025 in Stockholm, the premier Nordic life sciences event.
Programme elements
Programme details will be released at a later date. Make sure to register your interest for the event and get notified when changes are published.
As a participant in the Norwegian pavilion, your company will gain prime visibility with global investors, decision-makers, and potential collaborators in biopharma, medtech, and digital health. Be part of Norway’s national initiative to share our innovative health solutions with the world.
What’s Included:
Access to exclusive networking and partnership opportunities! More information will follow, for questions in relation to the event, please reach out to us.
Being a pavilion partner gives the following benefits:
- Your logo on the Pavilion backdrop
- You can submit a video (up to 60 seconds in length) that will be displayed in rotation at the Pavilion.
- One contact person on any 'Recommended invitation list' for a related event that may be arranged. (A pre-NLSDays event the afternoon prior)
- Access to a 15% discount code for you to register yourself, and colleagues from your institution/company.
Contact us or for more information!
Important conditions
Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.
Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.
Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.